Report cover image

Global T-cell Therapy Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18750491

Description

Global T-cell Therapy Databank Market Report


The T-cell Therapy market was valued at $2,851.6 Million in 2022, and is projected to reach $29,563.2 Million by 2031 growing at a CAGR of 29.88% from 2023 to 2031. Tumor Infiltrating Lymphocytes (TIL)-based segment is expected to be the highest contributor to this market, with $2,191.5 Million in 2022, and is anticipated to reach $21,789.1 Million by 2031, registering a CAGR of 29.27%. CAR T-cell Therapy segment is anticipated to reach $2,551.9 Million by 2031 with the highest CAGR of 34.26%. Tumor Infiltrating Lymphocytes (TIL)-based and T Cell Receptor (TCR)-based segments collectively expected to account for about 93.6% share of the T-cell Therapy market in 2022, with the former constituting around 76.9% share. CAR T-cell Therapy and T Cell Receptor (TCR)-based segments are expected to witness significant growth rates at a CAGR of 34.26% and 30.62% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 23.1% in the overall T-cell Therapy market in 2022, and is anticipated to reach 26.3% by 2031.

Table of Contents

100 Pages
1. Global T-cell Therapy Market, By Therapy Type
1.1. Overview
1.2. CAR T-cell Therapy
1.2.1 CAR T-cell Therapy Market, By Region
1.2.1.1 North America CAR T-cell Therapy Market, By Country
1.2.1.2 Europe CAR T-cell Therapy Market, By Country
1.2.1.3 Asia-Pacific CAR T-cell Therapy Market, By Country
1.2.1.4 Rest of World CAR T-cell Therapy Market, By Country
1.3. T Cell Receptor (TCR)-based
1.3.1 T Cell Receptor (TCR)-based Market, By Region
1.3.1.1 North America T Cell Receptor (TCR)-based Market, By Country
1.3.1.2 Europe T Cell Receptor (TCR)-based Market, By Country
1.3.1.3 Asia-Pacific T Cell Receptor (TCR)-based Market, By Country
1.3.1.4 Rest of World T Cell Receptor (TCR)-based Market, By Country
1.4. Tumor Infiltrating Lymphocytes (TIL)-based
1.4.1 Tumor Infiltrating Lymphocytes (TIL)-based Market, By Region
1.4.1.1 North America Tumor Infiltrating Lymphocytes (TIL)-based Market, By Country
1.4.1.2 Europe Tumor Infiltrating Lymphocytes (TIL)-based Market, By Country
1.4.1.3 Asia-Pacific Tumor Infiltrating Lymphocytes (TIL)-based Market, By Country
1.4.1.4 Rest of World Tumor Infiltrating Lymphocytes (TIL)-based Market, By Country
2. Global T-cell Therapy Market, By Indication
2.1. Overview
2.2. Hematologic Malignancies
2.2.1 Hematologic Malignancies Market, By Region
2.2.1.1 North America Hematologic Malignancies Market, By Country
2.2.1.2 Europe Hematologic Malignancies Market, By Country
2.2.1.3 Asia-Pacific Hematologic Malignancies Market, By Country
2.2.1.4 Rest of World Hematologic Malignancies Market, By Country
2.3. Solid Tumors
2.3.1 Solid Tumors Market, By Region
2.3.1.1 North America Solid Tumors Market, By Country
2.3.1.2 Europe Solid Tumors Market, By Country
2.3.1.3 Asia-Pacific Solid Tumors Market, By Country
2.3.1.4 Rest of World Solid Tumors Market, By Country
2.4. Other Indications
2.4.1 Other Indications Market, By Region
2.4.1.1 North America Other Indications Market, By Country
2.4.1.2 Europe Other Indications Market, By Country
2.4.1.3 Asia-Pacific Other Indications Market, By Country
2.4.1.4 Rest of World Other Indications Market, By Country
3. Global T-cell Therapy Market, By Region
3.1. Overview
3.2. North America
3.2.1 North America T-cell Therapy Market, By Therapy Type
3.2.2 North America T-cell Therapy Market, By Indication
3.2.3 North America T-cell Therapy Market, By Country
3.2.3.1 U.S.
3.2.3.1.1 U.S. T-cell Therapy Market, By Therapy Type
3.2.3.1.2 U.S. T-cell Therapy Market, By Indication
3.2.3.2 Canada
3.2.3.2.1 Canada T-cell Therapy Market, By Therapy Type
3.2.3.2.2 Canada T-cell Therapy Market, By Indication
3.3. Europe
3.3.1 Europe T-cell Therapy Market, By Therapy Type
3.3.2 Europe T-cell Therapy Market, By Indication
3.3.3 Europe T-cell Therapy Market, By Country
3.3.3.1 Germany
3.3.3.1.1 Germany T-cell Therapy Market, By Therapy Type
3.3.3.1.2 Germany T-cell Therapy Market, By Indication
3.3.3.2 U.K.
3.3.3.2.1 U.K. T-cell Therapy Market, By Therapy Type
3.3.3.2.2 U.K. T-cell Therapy Market, By Indication
3.3.3.3 France
3.3.3.3.1 France T-cell Therapy Market, By Therapy Type
3.3.3.3.2 France T-cell Therapy Market, By Indication
3.3.3.4 Italy
3.3.3.4.1 Italy T-cell Therapy Market, By Therapy Type
3.3.3.4.2 Italy T-cell Therapy Market, By Indication
3.3.3.5 Spain
3.3.3.5.1 Spain T-cell Therapy Market, By Therapy Type
3.3.3.5.2 Spain T-cell Therapy Market, By Indication
3.3.3.6 Rest of Europe
3.3.3.6.1 Rest of Europe T-cell Therapy Market, By Therapy Type
3.3.3.6.2 Rest of Europe T-cell Therapy Market, By Indication
3.4. Asia-Pacific
3.4.1 Asia-Pacific T-cell Therapy Market, By Therapy Type
3.4.2 Asia-Pacific T-cell Therapy Market, By Indication
3.4.3 Asia-Pacific T-cell Therapy Market, By Country
3.4.3.1 China
3.4.3.1.1 China T-cell Therapy Market, By Therapy Type
3.4.3.1.2 China T-cell Therapy Market, By Indication
3.4.3.2 Japan
3.4.3.2.1 Japan T-cell Therapy Market, By Therapy Type
3.4.3.2.2 Japan T-cell Therapy Market, By Indication
3.4.3.3 India
3.4.3.3.1 India T-cell Therapy Market, By Therapy Type
3.4.3.3.2 India T-cell Therapy Market, By Indication
3.4.3.4 Singapore
3.4.3.4.1 Singapore T-cell Therapy Market, By Therapy Type
3.4.3.4.2 Singapore T-cell Therapy Market, By Indication
3.4.3.5 Rest of Asia
3.4.3.5.1 Rest of Asia T-cell Therapy Market, By Therapy Type
3.4.3.5.2 Rest of Asia T-cell Therapy Market, By Indication
3.5. Rest of World
3.5.1 Rest of World T-cell Therapy Market, By Therapy Type
3.5.2 Rest of World T-cell Therapy Market, By Indication
3.5.3 Rest of World T-cell Therapy Market, By Country
3.5.3.1 South Africa
3.5.3.1.1 South Africa T-cell Therapy Market, By Therapy Type
3.5.3.1.2 South Africa T-cell Therapy Market, By Indication
3.5.3.2 ROW Countries
3.5.3.2.1 ROW Countries T-cell Therapy Market, By Therapy Type
3.5.3.2.2 ROW Countries T-cell Therapy Market, By Indication
ROW Countries T-cell Therapy Market Value, By Indication, 2022-2031, Million USD LIST OF TABLES
TABLE 1. Global T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 2. CAR T-cell Therapy Market Value, By Region, 2022-2031, Million USD
TABLE 3. North America CAR T-cell Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 4. Europe CAR T-cell Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 5. Asia-Pacific CAR T-cell Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 6. Rest of World CAR T-cell Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 7. T Cell Receptor (TCR)-based Market Value, By Region, 2022-2031, Million USD
TABLE 8. North America T Cell Receptor (TCR)-based Market Value, By Country, 2022-2031, Million USD
TABLE 9. Europe T Cell Receptor (TCR)-based Market Value, By Country, 2022-2031, Million USD
TABLE 10. Asia-Pacific T Cell Receptor (TCR)-based Market Value, By Country, 2022-2031, Million USD
TABLE 11. Rest of World T Cell Receptor (TCR)-based Market Value, By Country, 2022-2031, Million USD
TABLE 12. Tumor Infiltrating Lymphocytes (TIL)-based Market Value, By Region, 2022-2031, Million USD
TABLE 13. North America Tumor Infiltrating Lymphocytes (TIL)-based Market Value, By Country, 2022-2031, Million USD
TABLE 14. Europe Tumor Infiltrating Lymphocytes (TIL)-based Market Value, By Country, 2022-2031, Million USD
TABLE 15. Asia-Pacific Tumor Infiltrating Lymphocytes (TIL)-based Market Value, By Country, 2022-2031, Million USD
TABLE 16. Rest of World Tumor Infiltrating Lymphocytes (TIL)-based Market Value, By Country, 2022-2031, Million USD
TABLE 17. Global T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 18. Hematologic Malignancies Market Value, By Region, 2022-2031, Million USD
TABLE 19. North America Hematologic Malignancies Market Value, By Country, 2022-2031, Million USD
TABLE 20. Europe Hematologic Malignancies Market Value, By Country, 2022-2031, Million USD
TABLE 21. Asia-Pacific Hematologic Malignancies Market Value, By Country, 2022-2031, Million USD
TABLE 22. Rest of World Hematologic Malignancies Market Value, By Country, 2022-2031, Million USD
TABLE 23. Solid Tumors Market Value, By Region, 2022-2031, Million USD
TABLE 24. North America Solid Tumors Market Value, By Country, 2022-2031, Million USD
TABLE 25. Europe Solid Tumors Market Value, By Country, 2022-2031, Million USD
TABLE 26. Asia-Pacific Solid Tumors Market Value, By Country, 2022-2031, Million USD
TABLE 27. Rest of World Solid Tumors Market Value, By Country, 2022-2031, Million USD
TABLE 28. Other Indications Market Value, By Region, 2022-2031, Million USD
TABLE 29. North America Other Indications Market Value, By Country, 2022-2031, Million USD
TABLE 30. Europe Other Indications Market Value, By Country, 2022-2031, Million USD
TABLE 31. Asia-Pacific Other Indications Market Value, By Country, 2022-2031, Million USD
TABLE 32. Rest of World Other Indications Market Value, By Country, 2022-2031, Million USD
TABLE 33. Global T-cell Therapy Market Value, By Region, 2022-2031, Million USD
TABLE 34. North America T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 35. North America T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 36. North America T-cell Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 37. U.S. T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 38. U.S. T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 39. Canada T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 40. Canada T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 41. Europe T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 42. Europe T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 43. Europe T-cell Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 44. Germany T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 45. Germany T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 46. U.K. T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 47. U.K. T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 48. France T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 49. France T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 50. Italy T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 51. Italy T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 52. Spain T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 53. Spain T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 54. Rest of Europe T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 55. Rest of Europe T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 56. Asia-Pacific T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 57. Asia-Pacific T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 58. Asia-Pacific T-cell Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 59. China T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 60. China T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 61. Japan T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 62. Japan T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 63. India T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 64. India T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 65. Singapore T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 66. Singapore T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 67. Rest of Asia T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 68. Rest of Asia T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 69. Rest of World T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 70. Rest of World T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 71. Rest of World T-cell Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 72. South Africa T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 73. South Africa T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
TABLE 74. ROW Countries T-cell Therapy Market Value, By Therapy Type, 2022-2031, Million USD
TABLE 75. ROW Countries T-cell Therapy Market Value, By Indication, 2022-2031, Million USD
ROW Countries T-cell Therapy Market Value, By Indication, 2022-2031, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us